Phathom completes enrollment in vonoprazan trial for EoE
Phathom completes enrollment in vonoprazan trial for EoE
Phathom completes enrollment in vonoprazan trial for EoE
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.